Yahoo Web Search

Search results

    • Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO

      Benzinga· 3 hours ago

      BEIJING and SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C inhibitor glecirasib